vs

Side-by-side financial comparison of CME Group (CME) and ON Semiconductor (ON). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.6B, roughly 1.2× ON Semiconductor). ON Semiconductor runs the higher net margin — 16.4% vs 0.1%, a 16.4% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -10.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -12.3%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Fairchild Semiconductor International, Inc. was an American semiconductor company based in San Jose, California. It was founded in 1957 as a division of Fairchild Camera and Instrument by the "traitorous eight" who defected from Shockley Semiconductor Laboratory. It became a pioneer in the manufacturing of transistors and of integrated circuits. Schlumberger bought the firm in 1979 and sold it to National Semiconductor in 1987; Fairchild was spun off as an independent company again in 1997. I...

CME vs ON — Head-to-Head

Bigger by revenue
CME
CME
1.2× larger
CME
$1.9B
$1.6B
ON
Growing faster (revenue YoY)
CME
CME
+24.4% gap
CME
14.5%
-10.0%
ON
Higher net margin
ON
ON
16.4% more per $
ON
16.4%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-12.3%
ON

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CME
CME
ON
ON
Revenue
$1.9B
$1.6B
Net Profit
$1.2M
$255.0M
Gross Margin
37.9%
Operating Margin
0.1%
17.0%
Net Margin
0.1%
16.4%
Revenue YoY
14.5%
-10.0%
Net Profit YoY
20.7%
-32.9%
EPS (diluted)
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
ON
ON
Q1 26
$1.9B
Q4 25
$1.6B
$1.6B
Q3 25
$1.5B
$1.5B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
Q4 24
$1.5B
$1.7B
Q3 24
$1.6B
$1.8B
Q2 24
$1.5B
$1.7B
Net Profit
CME
CME
ON
ON
Q1 26
$1.2M
Q4 25
$1.2B
$255.0M
Q3 25
$908.0M
$170.3M
Q2 25
$1.0B
$-486.1M
Q1 25
$956.2M
Q4 24
$874.6M
$379.9M
Q3 24
$912.8M
$401.7M
Q2 24
$883.2M
$338.2M
Gross Margin
CME
CME
ON
ON
Q1 26
Q4 25
37.9%
Q3 25
37.6%
Q2 25
20.3%
Q1 25
Q4 24
45.2%
Q3 24
45.4%
Q2 24
45.2%
Operating Margin
CME
CME
ON
ON
Q1 26
0.1%
Q4 25
61.8%
17.0%
Q3 25
63.3%
13.2%
Q2 25
66.7%
-39.7%
Q1 25
67.5%
Q4 24
62.1%
23.7%
Q3 24
64.6%
25.3%
Q2 24
65.3%
22.4%
Net Margin
CME
CME
ON
ON
Q1 26
0.1%
Q4 25
71.7%
16.4%
Q3 25
59.1%
11.6%
Q2 25
60.6%
-33.6%
Q1 25
58.2%
Q4 24
57.3%
22.1%
Q3 24
57.6%
22.8%
Q2 24
57.6%
19.5%
EPS (diluted)
CME
CME
ON
ON
Q1 26
Q4 25
$3.24
$0.63
Q3 25
$2.49
$0.41
Q2 25
$2.81
$-1.15
Q1 25
$2.62
Q4 24
$2.40
$0.88
Q3 24
$2.50
$0.93
Q2 24
$2.42
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
ON
ON
Cash + ST InvestmentsLiquidity on hand
$2.4B
$2.9B
Total DebtLower is stronger
$3.4B
$3.4B
Stockholders' EquityBook value
$7.9B
Total Assets
$202.0B
$13.0B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
ON
ON
Q1 26
$2.4B
Q4 25
$4.5B
$2.9B
Q3 25
$2.6B
$2.8B
Q2 25
$2.1B
$3.0B
Q1 25
$1.5B
Q4 24
$3.0B
$3.0B
Q3 24
$2.4B
$2.8B
Q2 24
$1.9B
$2.7B
Total Debt
CME
CME
ON
ON
Q1 26
$3.4B
Q4 25
$3.4B
Q3 25
$3.4B
Q2 25
$3.4B
Q1 25
Q4 24
$3.4B
Q3 24
$3.4B
Q2 24
$3.4B
Stockholders' Equity
CME
CME
ON
ON
Q1 26
Q4 25
$28.7B
$7.9B
Q3 25
$28.2B
$7.9B
Q2 25
$27.7B
$8.0B
Q1 25
$27.0B
Q4 24
$26.5B
$8.8B
Q3 24
$28.2B
$8.6B
Q2 24
$27.6B
$8.3B
Total Assets
CME
CME
ON
ON
Q1 26
$202.0B
Q4 25
$198.4B
$13.0B
Q3 25
$187.1B
$13.1B
Q2 25
$179.9B
$13.3B
Q1 25
$157.8B
Q4 24
$137.4B
$14.1B
Q3 24
$137.8B
$13.9B
Q2 24
$123.4B
$13.7B
Debt / Equity
CME
CME
ON
ON
Q1 26
Q4 25
0.43×
Q3 25
0.43×
Q2 25
0.42×
Q1 25
Q4 24
0.38×
Q3 24
0.39×
Q2 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
ON
ON
Operating Cash FlowLast quarter
$418.7M
Free Cash FlowOCF − Capex
$372.4M
FCF MarginFCF / Revenue
24.0%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
ON
ON
Q1 26
Q4 25
$1.1B
$418.7M
Q3 25
$968.1M
$184.3M
Q2 25
$1.1B
$602.3M
Q1 25
$1.1B
Q4 24
$1.0B
$579.7M
Q3 24
$1.0B
$465.8M
Q2 24
$776.9M
$362.2M
Free Cash Flow
CME
CME
ON
ON
Q1 26
Q4 25
$1.1B
$372.4M
Q3 25
$949.7M
$106.1M
Q2 25
$1.0B
$454.7M
Q1 25
$1.1B
Q4 24
$991.7M
$434.8M
Q3 24
$973.2M
$293.6M
Q2 24
$758.7M
$207.7M
FCF Margin
CME
CME
ON
ON
Q1 26
Q4 25
66.8%
24.0%
Q3 25
61.8%
7.2%
Q2 25
61.5%
31.5%
Q1 25
67.1%
Q4 24
65.0%
25.2%
Q3 24
61.4%
16.7%
Q2 24
49.5%
12.0%
Capex Intensity
CME
CME
ON
ON
Q1 26
Q4 25
2.0%
3.0%
Q3 25
1.2%
5.3%
Q2 25
1.1%
10.2%
Q1 25
0.9%
Q4 24
1.7%
8.4%
Q3 24
1.9%
9.8%
Q2 24
1.2%
8.9%
Cash Conversion
CME
CME
ON
ON
Q1 26
Q4 25
0.96×
1.64×
Q3 25
1.07×
1.08×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
1.53×
Q3 24
1.10×
1.16×
Q2 24
0.88×
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

ON
ON

Industrial Segment$426.3M27%
Other End Markets Segment$337.3M22%
Intelligent Sensing Segments$284.0M18%
Direct Customers$282.4M18%
Intelligent Sensing Group$230.0M15%

Related Comparisons